Author:
Li Wei,Chai Jin-Lian,Li Zhe,Guo Cong-Cong,Wei Ran,Sun Tie-Feng,Liang Xue-Zhen
Abstract
Abstract
Objective
This study aimed to examine whether diabetes mellitus is causally associated with osteonecrosis.
Method
Using publicly accessible genome-wide association study statistics, a bidirectional two-sample Mendelian randomization analysis was carried out. In order to determine whether diabetes has a causal effect on osteonecrosis and whether osteonecrosis has a causal effect on diabetes, we extracted six date on diabetes in Europeans from IEU OpenGWAS and GWAS Catalogue and osteonecrosis in Europeans from FinnGen. We then evaluated the data using inverse variance weighting, MR-Egger regression, weighted median, weighted mode, and simple mode. The results’ stability and dependability were then evaluated using sensitivity analysis and heterogeneity analysis. Finally, meta-analysis is used to further confirm if there is a relationship between diabetes and osteonecrosis.
Results
When diabetes was used as an exposure factor, MR-Egger regression showed that directional fold product was unlikely to bias the results. Cochran’s Q test showed only minor heterogeneity in a few data sets. Multidirectional tests Egger-intercept, MR-PRESSO and funnel plots for most data did not show multidirectional and asymmetry at the gene level. Most of the IVW results showed no causal relationship between diabetes mellitus and osteonecrosis. The results of meta-analysis of IVW methods further confirmed the absence of a causal relationship. Inverse MR analysis also showed no causal relationship between osteonecrosis and diabetes.
Conclusion
Results of bidirectional MR analysis show no evidence of causal relationship between diabetes and osteonecrosis.
Funder
National Natural Science Foundation of China
National Natural Science Foundation of Shandong Province
Publisher
Springer Science and Business Media LLC
Subject
Orthopedics and Sports Medicine,Surgery
Reference61 articles.
1. Osteonecrosis PK. Baillieres. Best Pract Res Clin Rheumatol. 2000;14(2):399–414.
2. Migliorini F, Maffulli N, Eschweiler J, et al. Core decompression isolated or combined with bone marrow-derived cell therapies for femoral head osteonecrosis. Expert Opin Biol Ther. 2021;21(3):423–30.
3. Felten R, Perrin P, Caillard S, et al. Avascular osteonecrosis in kidney transplant recipients: Risk factors in a recent cohort study and evaluation of the role of secondary hyperparathyroidism. PLoS ONE. 2019;14(2): e0212931.
4. Beckmann R, Shaheen H, Kweider N, et al. Enoxaparin prevents steroid-related avascular necrosis of the femoral head. Sci World J. 2014;2014: 347813.
5. Chen H, Xu J, Lv Y, et al. Proanthocyanidins exert a neuroprotective effect via ROS/JNK signaling in MPTP-induced Parkinson’s disease models in vitro and in vivo. Mol Med Rep. 2018;18(6):4913–21.